Alia Therapeutics
Trento
About Alia Therapeutics
Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.3M
- Funding stage: Seed
- Last round: Seed (Apr 2023)
- Website: aliatherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/alia-therapeutics-148590 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.